Abraham Weizman obtained his MD degree from the Sackler Faculty of Medicine at Tel Aviv University in Israel and subsequently spent 2 years as a visiting scientist at NIMH in Bethesda, MD. He is a Professor of Child and Adult Psychiatry and an Adjunct Professor of Physiology and Pharmacology at the Faculty of Medical and Health Sciences at Tel Aviv University. He is also Head of the Research Unit at Geha Mental Health Center and Head of the Laboratory of Molecular and Biological Psychiatry at the Felsenstein Medical Research Center as well as the Center’s former Director. Professor Weizman investigates brain mechanisms of mental disorders. His research is both basic and clinical, and it focuses on neurodevelopmental disorders, the development of new strategies for the treatment of psychiatric disorders, and the psychopharmacology of mental disorders in children and adults. Additionally, he studies the role of the 18 kDa translocator protein (TSPO) in cell proliferation, steroidogenesis, cell-death, inflammation, neurodegeneration, and psychiatric disorders.